Skip to content

Teriparatide (PTH 1-34) studies: 484 papers with results

Page 8 of 10

  1. Effect of human parathyroid hormone (PTH(1-34)) on experimental osteopenia of rats induced by ovariectomy.

    Hori M · Bone and mineral · 1988

    Animal study (in vivo) · rat · 4 results

  2. Recombinant human parathyroid hormone (PTH 1-34) and low-intensity pulsed ultrasound have contrasting additive effects during fracture healing.

    Warden SJ · Bone · 2009

    Animal study (in vivo) · sprague-dawley rats · 7 results

  3. Frequency of Teriparatide Administration Affects the Histological Pattern of Bone Formation in Young Adult Male Mice.

    Yamamoto T · Endocrinology · 2016

    Animal study (in vivo) · mouse · 5 results

  4. Short-term continuous infusion of human parathyroid hormone 1-34 fragment is catabolic with decreased trabecular connectivity density accompanied by hypercalcemia in C57BL/J6 mice.

    Iida-Klein A · The Journal of endocrinology · 2005

    Animal study (in vivo) · mus musculus · 11 results

  5. Effects of combined treatment of insulin and human parathyroid hormone(1-34) on cancellous bone mass and structure in streptozotocin-induced diabetic rats.

    Suzuki K · Bone · 2003

    Animal study (in vivo) · rat · 12 results

  6. Promotion of peri-implant bone healing by systemically administered parathyroid hormone (1-34) and zoledronic acid adsorbed onto the implant surface.

    Li YF · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2013

    Animal study (in vivo) · rat · 4 results

  7. Anabolic and catabolic regimens of human parathyroid hormone 1-34 elicit bone- and envelope-specific attenuation of skeletal effects in Sost-deficient mice.

    Robling AG · Endocrinology · 2011

    Animal study (in vivo) · mouse · 7 results

  8. Anabolic effect of human synthetic parathyroid hormone-(1-34) depends on growth hormone.

    Hock JM · Endocrinology · 1990

    Animal study (in vivo) · rat · 7 results

  9. Restoration of axial and appendicular bone volumes by h-PTH(1-34) in parathyroidectomized and osteopenic rats.

    Tada K · Bone · 1990

    Animal study (in vivo) · rat · 9 results

  10. Effect of intermittent systemic administration of recombinant parathyroid hormone (1-34) on mandibular fracture healing in rats.

    Rowshan HH · Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons · 2010

    Animal study (in vivo) · male sprague-dawley rats · 4 results

  11. Human parathyroid hormone(1-34) increases bone formation and strength of cortical bone in aged rats.

    Ejersted C · European journal of endocrinology · 1994

    Animal study (in vivo) · rat · 15 results

  12. MicroRNA levels in bone and blood change during bisphosphonate and teriparatide therapy in an animal model of postmenopausal osteoporosis.

    Kocijan R · Bone · 2020

    Animal study (in vivo) · sprague-dawley rats · 4 results

  13. Effect of teriparatide [rhPTH(1,34)] and calcitonin on intertransverse process fusion in a rabbit model.

    Lehman RA Jr · Spine · 2010

    Animal study (in vivo) · new zealand white rabbits · 6 results

  14. PTH [1-34] enhances bone response around titanium implants in a rabbit model of osteoporosis.

    Almagro MI · Clinical oral implants research · 2013

    Animal study (in vivo) · rabbit · 5 results

  15. Teriparatide therapy enhances devitalized femoral allograft osseointegration and biomechanics in a murine model.

    Reynolds DG · Bone · 2011

    Animal study (in vivo) · c57bl and 6 mice · 7 results

  16. Effect of treatment for 6 months with human parathyroid hormone (1-34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis).

    Jerome CP · Bone · 1999

    Animal study (in vivo) · macaca fascicularis · 18 results

  17. Parathyroid hormone (1-34) prevents cartilage degradation and preserves subchondral bone micro-architecture in guinea pigs with spontaneous osteoarthritis.

    Yan JY · Osteoarthritis and cartilage · 2014

    Animal study (in vivo) · guinea pig · 9 results

  18. Parathyroid hormone-(1-34) ameliorated knee osteoarthritis in rats via autophagy.

    Chen CH · Journal of applied physiology (Bethesda, Md. : 1985) · 2018

    Animal study (in vivo) · rat · 12 results

  19. Differential effects of intermittent PTH(1-34) and PTH(7-34) on bone microarchitecture and aortic calcification in experimental renal failure.

    Sebastian EM · Bone · 2008

    Animal study (in vivo) · rat · 8 results

  20. Abaloparatide exhibits greater osteoanabolic response and higher cAMP stimulation and β-arrestin recruitment than teriparatide.

    Sahbani K · Physiological reports · 2019

    Animal study (in vivo) · mouse · 25 results

  21. Effect of Intermittent Administration of Teriparatide (Parathyroid Hormone 1-34) on Bone Morphogenetic Protein-Induced Bone Formation in a Rat Model of Spinal Fusion.

    Morimoto T · The Journal of bone and joint surgery. American volume · 2014

    Animal study (in vivo) · rat · 7 results

  22. Combined effects of recombinant human BMP-7 (rhBMP-7) and parathyroid hormone (1-34) in metaphyseal bone healing.

    Morgan EF · Bone · 2008

    Animal study (in vivo) · rabbit · 16 results

  23. Intermittent administration of parathyroid hormone (1-34) stimulates matrix metalloproteinase-9 (MMP-9) expression in rat long bone.

    McClelland P · Journal of cellular biochemistry · 1998

    Animal study (in vivo) · rat · 4 results

  24. Abaloparatide Exerts Bone Anabolic Effects with Less Stimulation of Bone Resorption-Related Factors: A Comparison with Teriparatide.

    Makino A · Calcified tissue international · 2018

    Animal study (in vivo) · rat · 24 results

  25. Catabolic Effects of Human PTH (1-34) on Bone: Requirement of Monocyte Chemoattractant Protein-1 in Murine Model of Hyperparathyroidism.

    Siddiqui JA · Scientific reports · 2017

    Animal study (in vivo) · mouse · 7 results

  26. PTH [1-34]-induced alterations of the subchondral bone provoke early osteoarthritis.

    Orth P · Osteoarthritis and cartilage · 2014

    Animal study (in vivo) · rabbit · 8 results

  27. Intermittent PTH (1-34) injection rescues the retarded skeletal development and postnatal lethality of mice mimicking human achondroplasia and thanatophoric dysplasia.

    Xie Y · Human molecular genetics · 2012

    Animal study (in vivo) · mouse · 10 results

  28. Intermittent administration of human parathyroid Hormone(1-34) prevents immobilization-related bone loss by regulating bone marrow capacity for bone cells in ddY mice.

    Sakai A · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 1999

    Animal study (in vivo) · mouse · 12 results

  29. Abaloparatide at the Same Dose Has the Same Effects on Bone as PTH (1-34) in Mice.

    Le Henaff C · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2020

    Animal study (in vivo) · mouse · 20 results

  30. Dose-dependent enhancement of spinal fusion in rats with teriparatide (PTH[1-34]).

    Ming N · Spine · 2012

    Animal study (in vivo) · rat · 16 results

  31. Fracture repair: modulation of fracture-callus and mechanical properties by sequential application of IL-6 following PTH 1-34 or PTH 28-48.

    Rozen N · Bone · 2007

    Animal study (in vivo) · rat · 7 results

  32. Effects of teriparatide on morphology of aortic calcification in aged hyperlipidemic mice.

    Hsu JJ · American journal of physiology. Heart and circulatory physiology · 2018

    Animal study (in vivo) · mouse · 5 results

  33. The effect of PTH(1-34) on fracture healing during different loading conditions.

    Ellegaard M · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2013

    Animal study (in vivo) · rat · 6 results

  34. Systemic application of teriparatide for steroid induced osteonecrosis in a rat model.

    Dong Y · BMC musculoskeletal disorders · 2015

    Animal study (in vivo) · rat · 5 results

  35. Additive effect of PTH (1-34) and zoledronate in the prevention of disuse osteopenia in rats.

    Vegger JB · Bone · 2014

    Animal study (in vivo) · rat · 6 results

  36. Combined treatment with PTH (1-34) and OPG increases bone volume and uniformity of mineralization in aged ovariectomized rats.

    Valenta A · Bone · 2005

    Animal study (in vivo) · rat · 3 results

  37. Experimental stimulation of bone healing with teriparatide: histomorphometric and microhardness analysis in a mouse model of closed fracture.

    Mognetti B · Calcified tissue international · 2011

    Animal study (in vivo) · mouse · 3 results

  38. LY353381 x HCl: an improved benzothiophene analog with bone efficacy complementary to parathyroid hormone-(1-34).

    Sato M · Endocrinology · 1998

    Animal study (in vivo) · rat · 12 results

  39. Effects of a weekly injection of human parathyroid hormone (1-34) and withdrawal on bone mass, strength, and turnover in mature ovariectomized rats.

    Okimoto N · Bone · 1998

    Animal study (in vivo) · rat · 16 results

  40. Abaloparatide versus teriparatide: a head to head comparison of effects on fracture healing in mouse models.

    Bernhardsson M · Acta orthopaedica · 2018

    Animal study (in vivo) · mouse · 8 results

  41. Teriparatide and exercise improve bone, skeletal muscle, and fat parameters in ovariectomized and tail-suspended rats.

    Sato C · Journal of bone and mineral metabolism · 2021

    Animal study (in vivo) · wistar rat · 7 results

  42. Enhanced bone morphogenetic protein-2-induced ectopic and orthotopic bone formation by intermittent parathyroid hormone (1-34) administration.

    Kempen DH · Tissue engineering. Part A · 2010

    Animal study (in vivo) · rat · 12 results

  43. Prevention of bone loss in ovariectomized rats by pulsatile transdermal iontophoretic administration of human PTH(1-34).

    Suzuki Y · Journal of pharmaceutical sciences · 2002

    Animal study (in vivo) · rat · 9 results

  44. PTH(1-34) treatment and/or mechanical loading have different osteogenic effects on the trabecular and cortical bone in the ovariectomized C57BL/6 mouse.

    Roberts BC · Scientific reports · 2020

    Animal study (in vivo) · mouse · 5 results

  45. Teriparatide Treatment Improves Bone Defect Healing Via Anabolic Effects on New Bone Formation and Non-Anabolic Effects on Inhibition of Mast Cells in a Murine Cranial Window Model.

    Zhang L · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2017

    Animal study (in vivo) · mouse · 6 results

  46. Effects of intermittent administration of low dose human PTH(1-34) on cancellous and cortical bone of lumbar vertebral bodies in adult beagles.

    Zhang L · Bone · 1997

    Animal study (in vivo) · dog · 9 results

  47. PTH (1-34) and growth hormone in prevention of disuse osteopenia and sarcopenia in rats.

    Brent MB · Bone · 2018

    Animal study (in vivo) · rat · 8 results

  48. Enhancement of Lumbar Fusion and Alleviation of Adjacent Segment Disc Degeneration by Intermittent PTH(1-34) in Ovariectomized Rats.

    Zhou Z · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2016

    Animal study (in vivo) · rat · 7 results

  49. Delayed short-course treatment with teriparatide (PTH(1-34)) improves femoral allograft healing by enhancing intramembranous bone formation at the graft-host junction.

    Takahata M · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2012

    Animal study (in vivo) · mouse · 8 results

  50. Teriparatide therapy and beta-tricalcium phosphate enhance scaffold reconstruction of mouse femoral defects.

    Jacobson JA · Tissue engineering. Part A · 2011

    Animal study (in vivo) · c57bl and 6 mice · 11 results

How PepBank reports evidence